Evaluation of the Diagnostic Potential of uPAR as a Biomarker in Renal Biopsies of Patients with FSGS

Table 1

Clinical-epidemiological profile of patients.

	MCD ()	FSGS ()	value
Age
			0.8484
Median (min–max)	34.5 (15-70)	36 (16-73)
Gender, n (%)
Male	6 (37.5%)	14 (63.64%)	0.1881
Female	10 (62.5%)	8 (36.36%)
Creatinine (mg/dl)
			0.0156
Median (min–max)	0.9 (0.5-2.4)	1.4 (0.8-3.0)
Proteinuria (g/24 h)
			0.0234
Median (min–max)	2.15 (0.16-6.19)	4.35 (1.24-14.46)
Albumin (mg/dl)
			0.8258
Median (min–max)	2.6 (1.4-4.6)	3.3 (0.8-3.9)
Hematuria
Yes	8 (50.00%)	6 (27.27%)	0.4905
No	8 (50.00%)	11 (50.00%)
Hypertension
Yes	4 (25.00%)	16 (72.73%)	0.0009
No	8 (50.00%)	1 (4.54%)

.